Search clinical trials for: RT CETUXIMAB

Total 3995 results

Xijing Hospital

Recruiting

A Small-sample, Real-world Study of Sintilimab Plus Bevacizumab/Cetuximab Plus XELOX Regimen for Conversion Therapy in Patients With Advanced Colorectal Cancer

Colorectal Cancer

China
National Cancer Institute, Naples

Recruiting

Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients (CIFRA)

Colorectal Cancer | ADCC

Italy
Hanmi Pharmaceutical Company Limited

Active, not recruiting

HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors

Metastatic Solid Tumor | Locally Advanced Solid Tumor

Korea, Republic of
Henan Cancer Hospital

Completed

Continuing Cetuximab Plus Chemotherapy After First Progression in Wild-type KRAS, NRAS and BRAF V600E Metastatic Colorectal Cancer

Wild-type KRAS,NRAS and BRAF V600E Metastatic Colorectal Cancer
National University Hospital, Singapore

Unknown

Reactivating NK Cells in Treating Refractory Head and Neck Cancer (NKEXPHNC)

Nasopharyngeal Cancer | Head and Neck Squamous Cell Carcinoma

Singapore
Shanghai General Hospital, Shanghai Jiao Tong University...

Unknown

Evaluation of CTCs Combined With Tumor Marker Detection of Efficacy of Chemotherapy in mCRC

Colorectal Cancer Metastatic
Gynecologic Oncology Group
Bristol-Myers Squibb; National Cancer Institute (NCI)

Completed

Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States, Norway, Canada, Australia, Japan
Fudan University

Unknown

Study of Cetuximab in Combination With mFOLFOX-6 (Oxaliplatin, Leucovorin, 5-FU) to Treat Colorectal Liver Metastatic Cancer Patients (CLIME)

Colorectal Cancer | Liver Metastases

China
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Cetuximab in Treating Patients With Stage IV Colorectal Cancer

Colorectal Cancer

United States
Gruppo Italiano per lo studio dei Carcinomi dell...
Mario Negri Institute for Pharmacological Research

Completed

Gemcitabine/Cisplatin +/-Cetuximab in Patients With Locally Advanced or Metastatic EGFR-Positive Pancreatic Cancer (SPaCe-01)

Pancreatic Cancer

Italy
QuantuMDx Group Ltd
PathAI; Bright Research Center; New Day Diagnostics

Completed

Q-POC SARS-CoV-2 Assay COVID-19 Clinical Evaluation

COVID-19

United States
Centre Hospitalier Intercommunal Creteil

Completed

Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department

Covid19

France
University College, London
Cancer Research UK

Unknown

Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer (SARON)

Non-small Cell Lung Cancer

United Kingdom
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Completed

Intensity Modulated Radiotherapy With Concomitant Boost in Breast Cancer

Breast Cancer | Radiation Toxicity
Korea University

Completed

Effect of Real Time Continuous Glucose Monitoring System on the Management of Type 2 Diabetes

Type 2 Diabetes

Korea, Republic of
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)

Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | Pertuzumab

China
McGill University
Canadian Institutes of Health Research (CIHR); Jewish Rehabilitation Hospital; The Memory Lab and other collaborators

Recruiting

Exercise to Improve Sleep in Parkinson's Disease

Parkinson Disease

Canada
Laminar Pharmaceuticals
Laboratory Corporation of America; Northern Institute for Cancer Research,... and other collaborators

Active, not recruiting

LAM561 With RT and TMZ for Adults With Glioblastoma (CLINGLIO)

Glioblastoma Multiforme | Primary Glioblastoma

Spain, Italy, United Kingdom, France, Israel
Mayo Clinic

Active, not recruiting

Moderately Hypofractionated Photon and Proton Chemoradiotherapy as Definitive or Neoadjuvant Therapy in Non-metastatic Pancreas Cancer With Assessment of Treatment Response Utilizing Molecular Biomarkers

Pancreatic Cancer

United States
Assaf-Harofeh Medical Center

Completed

Evaluating the Immune Response for COVID-19 (COVIDIMMUNE)

COVID-19

Israel
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Completed

Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer

Cervical Cancer | Endometrial Cancer | Radiation Toxicity | Perioperative/Postoperative Complications | Gastrointestinal Complications | Urinary Complications | Urinary Tract Toxicity

United States, Canada, Singapore, Hong Kong
Fundacio Puigvert

Unknown

The Utility of Enhanced Pre and Post-surgical Work-out to Prevent the Spread of COVID-19 in a Large Urology Department (UroCovid)

COVID-19 | Urologic Diseases | Surgery--Complications | Epidemic Disease

Spain
Statens Serum Institut

Completed

A Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®, in Combination With a Safety Assessment of C-Tb Versus Tuberculin PPD RT23 SSI

Tuberculosis

South Africa
Statens Serum Institut

Completed

Comparison of Diagnostic Performance of C-Tb to QuantiFERON®-TB, in Combination With a Safety Assessment of C-Tb vs Tuberculin PPD RT23 SSI

Tuberculosis

Spain
Maastricht University Medical Center

Completed

Effect of Hypnotherapy in Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome

Netherlands
Level 42 AI, Inc.
Asian Institute of Public Health; Institut de Recherche en Santé de Surveillance... and other collaborators

Completed

imPulse™ Una Infrasound-to-ultrasound E-stethoscope

Covid19 | Corona Virus Infection | COVID-19 Pneumonia | COVID-19 Respiratory Infection | COVID-19 Acute Respiratory Distress Syndrome | Mass Screening | Vaccine Virus Shedding

Congo, The Democratic Republic of the, India, Senegal
Gustave Roussy, Cancer Campus, Grand Paris
Merck Serono International SA

Completed

Biliary Cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin

Advanced Biliary Cancer

France
Bristol-Myers Squibb

Completed

BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies

Colorectal Cancer

United States, Canada, Netherlands
Tata Memorial Centre
Bhabha Atomic Research Centre (BARC)

Active, not recruiting

Artificial Intelligence in CNS Radiation Oncology (AI-RAD)

CNS Tumor

India
Radiation Therapy Oncology Group

Completed

Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma

Glioma | Astrocytoma | Glioblastoma Multiforme
European Institute of Oncology

Recruiting

Accelerated Modulated Fractionation (SIB-IMRT) for Head and Neck District (FAMOSO)

Carcinoma of the Head and Neck

Italy
Sichuan Cancer Hospital and Research Institute
Southwest Hospital, China; Affiliated Cancer Hospital & Institute of Guangzhou... and other collaborators

Unknown

Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Locally Advanced Thoracic Middle-lower Segment Esophageal Squamous Cell Carcinoma

China
Merck KGaA, Darmstadt, Germany

Completed

Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer (BALI-1)

Breast Neoplasm

Spain, United Kingdom, Germany, Australia, Austria, Belgium, Israel, New Zealand, Portugal, Italy, Ireland
National Taiwan University Hospital
Chang Gung Memorial Hospital; Taipei Veterans General Hospital, Taiwan; Tri-Service... and other collaborators

Completed

Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric Cancer (FLAG)

Gastric Cancer

Taiwan
Centre Oscar Lambret

Completed

Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery

Head and Neck Cancer

France
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Active, not recruiting

RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer

Head and Neck Cancer

United States, Canada, Saudi Arabia, China
Novartis Pharmaceuticals

Terminated

Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy

Metastatic Colorectal Cancer | Squamous Cell Carcinoma of Head and Neck (SCCHN)

France, Belgium, Spain, Germany, Italy, Canada, United States
Roswell Park Cancer Institute

Terminated

Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer

Head and Neck Cancer

United States
University of Alabama at Birmingham
National Cancer Institute (NCI)

Terminated

Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx

Head and Neck Cancer

United States
Pfizer
CVS Caremark

Recruiting

Patient Reported Health-Related Quality of Life Associated With COVID-19

COVID-19

United States
AstraZeneca

Recruiting

A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Recurrent Glioblastoma Multiforme | Brain Neoplasms, Malignant | Primary Glioblastoma Multiforme | Leptomeningeal Disease (LMD)

United States, United Kingdom
Tata Memorial Centre

Recruiting

Bladder Cancer Adjuvant Radiotherapy Trial (BART)

Bladder Cancer | Urothelial Carcinoma Bladder

India
Emory University

Completed

Resistance Training to Improve Fatigue and Physical Function in Postmenopausal Breast Cancer Survivors

Cancer

United States
Hospices Civils de Lyon

Completed

Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center (SurgiCovid)

Head and Neck Cancer | Digestive Cancer | Gynaecological Cancer

France
New Mexico Cancer Care Alliance

Terminated

IR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Large Lung Tumors

Recurrent Non-small Cell Lung Cancer

United States
Spanish Cooperative Group for the Treatment of...

Completed

Safety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Single Agent Cetuximab as Maintenance Therapy in Patients With Metastatic Colorectal Cancer and WT KRAS Tumours (MACRO-2)

Metastatic Colorectal Cancer

Spain
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute

Active, not recruiting

Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma

United States
Wugen, Inc.

Recruiting

A Phase 1b Study of WU-NK-101 in Combination With Cetuximab

Squamous Cell Carcinoma of Head and Neck | Colorectal Cancer Metastatic

United States
Eye & ENT Hospital of Fudan University

Recruiting

Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN

Head and Neck Neoplasms | Metastatic Cancer | Recurrent Disease

China
Bayer

Completed

Safety and Pharmacokinetics of Regorafenib and Cetuximab in Combination

Neoplasms

United States

Search clinical trials for: RT CETUXIMAB

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations